Cancer Therapy
Nanomedicine Breakthroughs Reshape Cancer Treatment Through Enhanced Drug Delivery
Advances in nanomedicine delivery systems are addressing critical limitations in cancer therapy by improving drug bioavailability and targeting while reducing toxicity, potentially transforming treatment standards across the oncology landscape.
GeoVax Executives Pursue European Partnerships to Advance Vaccine and Cancer Therapy Development
GeoVax Labs is intensifying European partnership efforts to accelerate development of vaccines for mpox, COVID-19, and cancer therapies, addressing critical global health needs.
GeoVax CEO to Present at ROTH Healthcare Conference, Highlighting Vaccine and Cancer Therapy Pipeline
GeoVax Labs' participation in the ROTH Healthcare Opportunities Conference provides investors with insights into the company's advancing vaccine and cancer therapy pipeline, including progress on Mpox, COVID-19 vaccines, and oncology treatments.
GeoVax Expands Gedeptin Cancer Therapy Development to Additional Solid Tumor Types
GeoVax Labs is expanding its Gedeptin cancer therapy development to include triple negative breast cancer and cutaneous malignancies, building on checkpoint inhibitor momentum and KEYNOTE-689 results to potentially improve outcomes for broader solid tumor patients.
Creative Biolabs Unveils Next-Generation CAR-T Engineering Platform for Smarter, Safer Cancer Therapy
Creative Biolabs introduces its Next CAR-T Engineering Platform, aiming to enhance the safety and efficacy of CAR-T cell therapy through advanced modular genetic programming and robust construct design.
GeoVax to Showcase Vaccine and Cancer Therapy Progress at Emerging Growth Conference
GeoVax Labs, Inc. will present updates on its GEO-MVA, GEO-CM04S1, and Gedeptin® programs at the Emerging Growth Conference, highlighting advancements in vaccine development and cancer therapy.
Calidi Biotherapeutics Appoints Experienced Life Science Leader Eric Poma as New CEO
Calidi Biotherapeutics has named Dr. Eric Poma as its new Chief Executive Officer, bringing over 30 years of life science expertise to guide the company's innovative cancer therapy development strategy.